The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control
The 2025 narrative review noted that despite the volume of preclinical work, well-controlled human trial data are scarce, and the regenerative findings should be interpreted accordingly (PMID 40789979)
Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity
The FDA prescribing information for Wegovy (semaglutide) reports musculoskeletal painincluding back pain and extremity painas possible side effects, as does the prescribing information for Zepbound (tirzepatide)
HEXADECAPEPTIDE NL-BPC-157: The world's first supplement containing HEXADECAPEPTIDE synthesized with the new patented technology NL-PEPTIDES.
A study found that people with higher blood glutathione levels were less likely to develop cataracts or glaucoma, while those with lower levels were at increased risk
